Atıf Formatları
Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. Acar Et Al. , "Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study," DIAGNOSTICS , vol.16, no.4, 2026

Acar, O. Et Al. 2026. Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study. DIAGNOSTICS , vol.16, no.4 .

Acar, O., AÇAR, Ç. R., ÖRGÜÇ, İ. Ş., EKİNCİ, F., ŞAHBAZLAR, M., & ERDOĞAN, A. P., (2026). Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study. DIAGNOSTICS , vol.16, no.4.

Acar, Omer Et Al. "Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study," DIAGNOSTICS , vol.16, no.4, 2026

Acar, Omer Et Al. "Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study." DIAGNOSTICS , vol.16, no.4, 2026

Acar, O. Et Al. (2026) . "Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study." DIAGNOSTICS , vol.16, no.4.

@article{article, author={Omer Acar Et Al. }, title={Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study}, journal={DIAGNOSTICS}, year=2026}